Publication Date
8-1-2025
Journal
Leukemia
DOI
10.1038/s41375-025-02673-9
PMID
40588567
PMCID
PMC12310510
PubMedCentral® Posted Date
6-30-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Metabolic reprogramming is a key focus of targeted therapies in acute myeloid leukemia (AML). The mitochondrial sirtuin SIRT5 removes succinyl groups from specific lysines and impacts cell metabolism, but its role in AML tumorigenesis has not been extensively explored. A recent study highlighted that SIRT5 regulates AML cell activity by modulating glutamine metabolism, but its molecular targets in AML remain unclear. This study aims to identify the substrates of SIRT5 in AML. It was found that a total of 83 proteins with 121 lysine (K) residues showed increased succinylation after SIRT5 knockdown, as determined by succinylome analysis of MOLM-13 cells. SIRT5 was validated to interact with HADHA, a key molecule in the fatty acid oxidation pathway. Knockdown of SIRT5 resulted in hypersuccinylation and reduced enzymatic activity of HADHA. Mimetic mutations of lysine indicated that SIRT5 desuccinylates HADHA at K644. Inhibiting SIRT5 or HADHA increased sensitivity to venetoclax (VEN) in both VEN-sensitive and VEN-resistant cell lines. SIRT5 knockdown enhanced VEN-mediated suppression of mitochondrial metabolism and improved the survival of AML-transplanted NSG mice when combined with VEN. This study reveals the role of SIRT5 in AML metabolic regulation and provides valuable insights for developing SIRT5-targeted drugs and combination therapies with metabolic inhibitors.
Keywords
Humans, Animals, Leukemia, Myeloid, Acute, Mice, Sirtuins, Sulfonamides, Mitochondria, Bridged Bicyclo Compounds, Heterocyclic, Xenograft Model Antitumor Assays, Antineoplastic Agents, Mice, Inbred NOD, Apoptosis, Tumor Cells, Cultured, Cell Line, Tumor
Published Open-Access
yes
Recommended Citation
Wang, Moran; Zhu, Ruiqi; Small, Donald; et al., "SIRT5 Inhibition Impairs Mitochondrial Metabolism and Enhances Venetoclax-Induced Elimination of Acute Myeloid Leukemia Cells" (2025). Faculty, Staff and Students Publications. 6030.
https://digitalcommons.library.tmc.edu/baylor_docs/6030
Included in
Medical Sciences Commons, Medical Specialties Commons, Mental and Social Health Commons, Psychiatry and Psychology Commons